Cardinal Health Inc (CAH) : Bridgewater Wealth Financial Management scooped up 19 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 6,561 shares of Cardinal Health Inc which is valued at $555,323.Cardinal Health Inc makes up approximately 0.20% of Bridgewater Wealth Financial Management’s portfolio.
Other Hedge Funds, Including , Brighton Jones reduced its stake in CAH by selling 268 shares or 8.94% in the most recent quarter. The Hedge Fund company now holds 2,729 shares of CAH which is valued at $230,983. Cardinal Health Inc makes up approx 0.04% of Brighton Jones’s portfolio.Aberdeen Asset Management Plcuk reduced its stake in CAH by selling 9,687 shares or 3.82% in the most recent quarter. The Hedge Fund company now holds 244,001 shares of CAH which is valued at $20,652,245. Cardinal Health Inc makes up approx 0.07% of Aberdeen Asset Management Plcuk’s portfolio. Copper Rock Capital Partners added CAH to its portfolio by purchasing 2,626 company shares during the most recent quarter which is valued at $218,720. Cardinal Health Inc makes up approx 0.02% of Copper Rock Capital Partners’s portfolio.Benjamin F. Edwards Company boosted its stake in CAH in the latest quarter, The investment management firm added 26 additional shares and now holds a total of 4,265 shares of Cardinal Health Inc which is valued at $350,924. Cardinal Health Inc makes up approx 0.07% of Benjamin F. Edwards Company’s portfolio.Hollencrest Securities reduced its stake in CAH by selling 82 shares or 2.58% in the most recent quarter. The Hedge Fund company now holds 3,099 shares of CAH which is valued at $249,098. Cardinal Health Inc makes up approx 0.04% of Hollencrest Securities’s portfolio.
Cardinal Health Inc closed down -0.58 points or -0.69% at $83.78 with 12,14,596 shares getting traded on Monday. Post opening the session at $84.64, the shares hit an intraday low of $83.61 and an intraday high of $84.7 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.